In NPC, the EBV-encoded latent membrane protein LMP2A augments LDs accumulation and enhances NPC cell metastatic potential by suppressing the expression of adipose triglyceride lipase (ATGL), a key lipid degradation enzyme [20]. Here, PNPLA2 is linked to nasopharyngeal carcinoma.